Sexually transmitted infections in persons living with HIV infection and estimated HIV transmission risk: trends over time from the DC Cohort.


Journal

Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554

Informations de publication

Date de publication:
03 2020
Historique:
received: 08 08 2019
revised: 07 11 2019
accepted: 25 11 2019
pubmed: 8 1 2020
medline: 1 7 2020
entrez: 8 1 2020
Statut: ppublish

Résumé

A rise in incidence of STIs has been noted in the USA and in the District of Columbia (DC). We aim to describe changes in incident STIs among persons in care for HIV in Washington, DC as well as trends in HIV viral load among those with incident STIs. We conducted a retrospective DC Cohort analysis (n=7810) measuring STI incidence (syphilis, gonorrhoea and chlamydia) as well as incare viral load (ICVL) and percentage with all viral loads less than the limit of detection (%<LLOD) by year (2012-2016) among those with incident STIs. From 2012 to 2016, the incidence of STIs increased: chlamydia from 2.1 to 3.4 cases/100 person-years (p=0.0006), gonorrhoea from 2.1 to 4.0 (p<0.0001), syphilis from 1.7 to 2.6 (p=0.0042) and any STI episode from 5.3 to 8.8 (p<0.0001). STI incidence rates increased for those aged 18-34 (from 13.2 to 23.2 cases/100 person-years, p<0.0001), cisgender men (from 6.5 to 11.5, p<0.0001), non-Hispanic whites (from 8.6 to 16.1, p=0.0003) and men who have sex with men (from 9.3 to 15.7, p<0.0001). During 2012-2016, the ICVL among those with incident STIs improved from 108 to 19 copies/mL and %<LLOD from 23.6% to 55.1%. However, even in 2016, younger participants, cisgender and transgender women, non-Hispanic blacks and Hispanics had higher ICVLs and lower %<LLOD. Rates of incident STIs rose among persons in care for HIV in Washington, DC, with improved but not optimal measures of HIV viral suppression. These findings inform focused interventions towards preventing STI transmission and ending the HIV epidemic.

Identifiants

pubmed: 31907326
pii: sextrans-2019-054216
doi: 10.1136/sextrans-2019-054216
pmc: PMC7031010
mid: NIHMS1544756
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-95

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI117970
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI152598
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069503
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069503
Pays : United States

Investigateurs

Jeffery Binkley (J)
Rob Taylor (R)
Nabil Rayeed (N)
Cheryl Akridge (C)
Stacey Purinton (S)
Qingjiang Hou (Q)
Jeff Naughton (J)
David Parfitt (D)
Lawrence D'Angelo (L)
Natella Rahkmanina (N)
Michael Kharfen (M)
Michael Serlin (M)
Princy Kumar (P)
David Parenti (D)
Alan Greenberg (A)
Maria Jaurretche (M)
Brittany Wilbourn (B)
James Peterson (J)
Morgan Byrne (M)
Yan Ma (Y)
Ronald Wilcox (R)
Sohail Rana (S)
Ricardo Fernandez (R)
Annick Hebou (A)
Carl Dieffenbach (C)
Henry Masur (H)
Jose Bordon (J)
Gebeyehu Teferi (G)

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

HIV Med. 2018 Apr;19(4):261-270
pubmed: 29368440
Lancet HIV. 2018 Aug;5(8):e438-e447
pubmed: 30025681
Open Forum Infect Dis. 2018 Jan 24;5(2):ofy017
pubmed: 29479550
Lancet. 2019 Jun 15;393(10189):2428-2438
pubmed: 31056293
J Am Med Inform Assoc. 2016 May;23(3):635-43
pubmed: 26721732
J Int AIDS Soc. 2018 Jul;21(7):e25164
pubmed: 29989338
PLoS Med. 2017 Dec 27;14(12):e1002481
pubmed: 29281640
Lancet HIV. 2016 Apr;3(4):e183-90
pubmed: 27036994
Lancet Infect Dis. 2018 Mar;18(3):308-317
pubmed: 29229440
Am J Public Health. 2012 Aug;102(8):1516-26
pubmed: 22698038
Sex Transm Dis. 1992 Mar-Apr;19(2):61-77
pubmed: 1595015

Auteurs

Alessandra Anna Secco (AA)

Infectious Diseases, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA allisecco@gmail.com.
Infectious Diseases Section, DC VA Medical Center, Washington, District of Columbia, USA.

Hana Akselrod (H)

Infectious Diseases, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.

Jonathan Czeresnia (J)

Internal Medicine, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.

Matthew Levy (M)

Department of Epidemiology and Biostatistics, George Washington University Milken Institute of Public Health, Washington, District of Columbia, USA.

Morgan Byrne (M)

Department of Epidemiology and Biostatistics, George Washington University Milken Institute of Public Health, Washington, District of Columbia, USA.

Anne Monroe (A)

Department of Epidemiology and Biostatistics, George Washington University Milken Institute of Public Health, Washington, District of Columbia, USA.

Jose Lucar (J)

Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Michael Horberg (M)

Department of Infectious Diseases, Mid-Atlantic Permanente Medical Group, Rockville, Maryland, USA.

Amanda Derryck Castel (AD)

Department of Epidemiology and Biostatistics, George Washington University Milken Institute of Public Health, Washington, District of Columbia, USA.

Rupali Doshi (R)

Department of Epidemiology and Biostatistics, George Washington University Milken Institute of Public Health, Washington, District of Columbia, USA.
HIV/AIDS, Hepatitis, STD, and TB Administration, District of Columbia Department of Health, Washington, District of Columbia, USA.

Heather Rivasplata (H)

Infectious Diseases Section, DC VA Medical Center, Washington, District of Columbia, USA.

Leah Squires (L)

Infectious Diseases Section, DC VA Medical Center, Washington, District of Columbia, USA.
Department of Psychology, DC VA Medical Center, Washington, District of Columbia, USA.

David Parenti (D)

Infectious Diseases, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.

Debra Benator (D)

Infectious Diseases, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
Infectious Diseases Section, DC VA Medical Center, Washington, District of Columbia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH